Delivery Order SPE2DB22D2206-SPE2DB25FJM54
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a $29.9K delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of 180 tablets of Mektovi 15 mg, a melanoma treatment medication. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of September 2, 2025. The order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Mektovi 15 mg tablets (180 count) with a ceiling value of $19,924.54. This firm fixed-price delivery order, which is expected to be completed by September 9, 2025, represents a non-competitive set-aside award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Mektovi is a branded pharmaceutical product...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,976.34 to AmerisourceBergen Drug Corp on August 16, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the prime contractor under its existing contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $16,589.43 to AmerisourceBergen Drug Corp on July 26, 2025, with ultimate completion by July 28, 2025. This firm fixed-price, non-set-aside delivery order represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at...
- The Defense Logistics Agency's Medical Supply Chain awarded a firm fixed-price delivery order valued at $14,497.99 to AmerisourceBergen Drug Corp on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order will be performed...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $2,724.96 to AmerisourceBergen Drug Corp on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle with DLA and carries no set-aside designation. The order will be fulfilled from the vendor's corporate office location in Conshohocken,...
- The Defense Logistics Agency's Medical Supply Chain awarded a $12,075.32 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The delivery order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania, where the company...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,068.48 to AmerisourceBergen Drug Corp on July 23, 2025, with a completion date of July 24, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle. The vendor, headquartered in Conshohocken, Pennsylvania, will perform work at its corporate office location and supply pharmaceutical and...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $19,064.80 to AmerisourceBergen Drug Corp on August 2, 2025, with an ultimate completion date of August 4, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which is valued at $999.99M and extends through December 2026. AmerisourceBergen, headquartered in...
- The U.S. Defense Logistics Agency (DLA), through its Medical Supply Chain division, awarded a delivery order valued at $16,589.43 to AmerisourceBergen Drug Corp on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJM54Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $9,962.26 on August 19, 2025, for the supply of Mektovi 15 mg tablets (180-count package), with completion scheduled for September 10, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The award carries no set-aside designation and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply medications, vaccines, and medical supplies to military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen fulfills a substantial portion of DLA's medical procurement requirements across multiple therapeutic domains, supporting Defense Health Agency operations, the U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.0k | 8/19/25 |